Ricevi le ultime notizie sulle azioni SPDR Series Trust SPDR S&P Biotech ETF con aggiornamenti su tendenze di mercato, dati finanziari e analisi di Benzinga. Rimani informato sulle performance di XBI

Ultime notizie per

SPDR Series Trust SPDR S&P Biotech ETF

Healthcare

Industrials

Other

In seeking to track the performance of the S&P Biotechnology Select Industry Index (the index), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index (S&P TMI).

Novavax Inc

Insmed Inc

Moderna Inc

Natera Inc

Dyne Therapeutics Inc

Revolution Medicines Inc Ser C Pc Pp

Ptc Therapeutics Inc

Blueprint Medicines Corp

United Therapeutics Corp

Amgen Inc.

Gilead Sciences Inc

Abbvie Inc

Biomarin Pharmaceutical Inc.

Vertex Pharmaceuticals Inc

Incyte Corp

Alnylam Pharmaceuticals Inc.

Halozyme Therapeutics Inc

Biogen Inc.

Neurocrine Biosciences Inc

Exact Sciences Corp.

Exelixis Inc

Regeneron Pharmaceuticals

Madrigal Pharmaceuticals Inc

Bridgebio Pharma Inc

Xenetic Biosciences Inc

US Treasury 6 Month Bill ETF

XBiotech Inc

Xenetic Biosciences Inc Warrants (19/07/2024)

Press Releases

Shareholder Group Led by Founder Mina Sooch Nominates Majority Slate of Director Candidates to the Board of Opus Genetics, Inc.

Comments

SPDR Series Trust SPDR S&P Biotech ETF Notizie sulle azioni

Notizie

Ultime notizie per

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO